The purpose of this study is to determine whether administration of a synbiotic, comprised on
inulin and a bifidobacterial probiotic will colonise the gut wall and down-regulate TNF-alpha
and other pro-inflammatory cytokines in the mucosa of Crohn's patients with active disease to
reduce mucosal inflammation and induce remission.